The Leadership Team at Calliditas Therapeutics is responsible for steering the company's strategic direction and ensuring the successful development and commercialization of its specialized pharmaceutical products, particularly Nefecon. This diverse team of executives focuses on regulatory compliance, market access, financial management, scientific innovation, and operational effectiveness to address significant unmet medical needs and drive growth in niche markets. By fostering collaboration across various departments, the Leadership Team aims to optimize patient outcomes and enhance the company’s impact in the realm of inflammatory renal diseases like IgA nephropathy.
Christopher Ngai
Vice President, Market Access
David Ferraro
Vice President Of Sales
Frank Bringstrup
Senior Vice President Regulato...
Fredrik Johansson
CFO
Henrik Nilsson
Vice President Quality Assuran...
Johan Häggblad
Chief Scientific Officer
Karin Göhlin
Vice President Project Managem...
Krassimir Mitchev
VP, Clinical Development Portf...
Renee Aguiar-Lucande...
Chief Executive Officer
Thierry Christophe
VP Research And Head Of Region
View all